rom the Department of Pediatric Endocrinology, Children's Hospital Medical Center of Ahari, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
Abstract: (3797 Views)
The GnRH analogue has been shown to be effective in the treatment of
precocious puberty when given as a daily subcutaneous injection. We studied
the effectiveness of a long-acting GnRH analogue, Triptoreline, for the
treatment of central precocity, by suppressing gonadotropin and estradiol
secretion in three children with true precocious puberty. One month after
single dose intramuscular injection of depot GnRH analog Triptoreline, our
patients showed significant decreases in serum estradiol and blunting of the
responses of LH and FSH to GnRH test. No adverse effects were noted
during the first six to eight months of treatment.